Compare Elder Pharma with TTK HEALTHCARE - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ELDER PHARMA vs TTK HEALTHCARE - Comparison Results

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ELDER PHARMA TTK HEALTHCARE ELDER PHARMA/
TTK HEALTHCARE
 
P/E (TTM) x -0.2 18.3 - View Chart
P/BV x 0.1 1.5 6.9% View Chart
Dividend Yield % 0.0 1.1 -  

Financials

 ELDER PHARMA   TTK HEALTHCARE
EQUITY SHARE DATA
    ELDER PHARMA
Jun-14
TTK HEALTHCARE
Mar-19
ELDER PHARMA/
TTK HEALTHCARE
5-Yr Chart
Click to enlarge
High Rs3801,215 31.3%   
Low Rs188610 30.8%   
Sales per share (Unadj.) Rs491.2444.4 110.5%  
Earnings per share (Unadj.) Rs-3.217.2 -18.4%  
Cash flow per share (Unadj.) Rs14.427.6 52.1%  
Dividends per share (Unadj.) Rs05.00 0.0%  
Dividend yield (eoy) %00.5 0.0%  
Book value per share (Unadj.) Rs376.5177.9 211.6%  
Shares outstanding (eoy) m20.5414.13 145.4%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x0.62.1 28.2%   
Avg P/E ratio x-89.352.9 -168.7%  
P/CF ratio (eoy) x19.733.0 59.7%  
Price / Book Value ratio x0.85.1 14.7%  
Dividend payout %029.0 0.0%   
Avg Mkt Cap Rs m5,83312,894 45.2%   
No. of employees `000NA2.3 0.0%   
Total wages/salary Rs m2,1791,307 166.7%   
Avg. sales/employee Rs ThNM2,715.7-  
Avg. wages/employee Rs ThNM565.3-  
Avg. net profit/employee Rs ThNM105.4-  
INCOME DATA
Net Sales Rs m10,0896,279 160.7%  
Other income Rs m25778 331.1%   
Total revenues Rs m10,3466,356 162.8%   
Gross profit Rs m-792496 -159.8%  
Depreciation Rs m361147 246.3%   
Interest Rs m2,75634 8,154.7%   
Profit before tax Rs m-3,653393 -930.4%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m3,7130-   
Tax Rs m125149 84.0%   
Profit after tax Rs m-65244 -26.8%  
Gross profit margin %-7.87.9 -99.4%  
Effective tax rate %-3.437.9 -9.0%   
Net profit margin %-0.63.9 -16.7%  
BALANCE SHEET DATA
Current assets Rs m9,2402,717 340.1%   
Current liabilities Rs m9,9981,571 636.5%   
Net working cap to sales %-7.518.3 -41.1%  
Current ratio x0.91.7 53.4%  
Inventory Days Days4632 144.0%  
Debtors Days Days6047 128.5%  
Net fixed assets Rs m10,124991 1,021.6%   
Share capital Rs m206141 145.6%   
"Free" reserves Rs m5,5822,373 235.2%   
Net worth Rs m7,7342,514 307.6%   
Long term debt Rs m4,8893 143,794.1%   
Total assets Rs m22,8824,158 550.3%  
Interest coverage x-0.312.6 -2.6%   
Debt to equity ratio x0.60 46,750.1%  
Sales to assets ratio x0.41.5 29.2%   
Return on assets %11.86.7 176.2%  
Return on equity %-0.89.7 -8.7%  
Return on capital %22.316.9 131.7%  
Exports to sales %3.03.6 84.7%   
Imports to sales %0.40.5 86.7%   
Exports (fob) Rs m307225 136.1%   
Imports (cif) Rs m4331 139.3%   
Fx inflow Rs m307225 136.1%   
Fx outflow Rs m12571 176.2%   
Net fx Rs m181154 117.7%   
CASH FLOW
From Operations Rs m11,754173 6,790.4%  
From Investments Rs m-56197 -580.8%  
From Financial Activity Rs m-6,762-307 2,200.4%  
Net Cashflow Rs m4,432-38 -11,755.2%  

Share Holding

Indian Promoters % 39.6 65.4 60.6%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 7.5 3.7 202.7%  
FIIs % 16.8 5.2 323.1%  
ADR/GDR % 0.0 0.0 -  
Free float % 36.1 25.8 139.9%  
Shareholders   16,479 12,723 129.5%  
Pledged promoter(s) holding % 77.6 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ELDER PHARMA With:   PFIZER  ABBOTT INDIA  PANACEA BIOTECH  WYETH LTD  GSK PHARMA  

Compare ELDER PHARMA With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 262 Points Lower; Oil & Gas and Banking Stocks Witness Selling(Closing)

Indian share markets witnessed negative trading activity throughout the day and ended lower. At the closing bell, the BSE Sensex stood lower by 262 points (down 0.7%).

Related Views on News

TTK HEALTHCARE Announces Quarterly Results (1QFY20); Net Profit Down 53.8% (Quarterly Result Update)

Aug 13, 2019 | Updated on Aug 13, 2019

For the quarter ended June 2019, TTK HEALTHCARE has posted a net profit of Rs 36 m (down 53.8% YoY). Sales on the other hand came in at Rs 2 bn (up 3.2% YoY). Read on for a complete analysis of TTK HEALTHCARE's quarterly results.

TTK HEALTHCARE 2018-19 Annual Report Analysis (Annual Result Update)

Jul 18, 2019 | Updated on Jul 18, 2019

Here's an analysis of the annual report of TTK HEALTHCARE for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of TTK HEALTHCARE. Also includes updates on the valuation of TTK HEALTHCARE.

TTK HEALTHCARE Announces Quarterly Results (4QFY19); Net Profit Down 38.0% (Quarterly Result Update)

Jun 12, 2019 | Updated on Jun 12, 2019

For the quarter ended March 2019, TTK HEALTHCARE has posted a net profit of Rs 50 m (down 38.0% YoY). Sales on the other hand came in at Rs 1 bn (down 3.8% YoY). Read on for a complete analysis of TTK HEALTHCARE's quarterly results.

TTK HEALTHCARE 2017-18 Annual Report Analysis (Annual Result Update)

Mar 27, 2019 | Updated on Mar 27, 2019

Here's an analysis of the annual report of TTK HEALTHCARE for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of TTK HEALTHCARE. Also includes updates on the valuation of TTK HEALTHCARE.

TTK HEALTHCARE Announces Quarterly Results (3QFY19); Net Profit Down 60.1% (Quarterly Result Update)

Feb 1, 2019 | Updated on Feb 1, 2019

For the quarter ended December 2018, TTK HEALTHCARE has posted a net profit of Rs 49 m (down 60.1% YoY). Sales on the other hand came in at Rs 1 bn (up 2.1% YoY). Read on for a complete analysis of TTK HEALTHCARE's quarterly results.

More Views on News

Most Popular

Buying these Eight Stocks is Like Owning Your Own Business(Profit Hunter)

Sep 5, 2019

Everyone dreams of owning a business. Here is your chance.

7 Stocks to Buy in the Market Today(The 5 Minute Wrapup)

Sep 5, 2019

The stock market had a four-year bull run starting September 2013. Are we seeing a similar pattern now?

Don't Buy Lakshmi Vilas Bank...Buy this Private Sector Bank with 74% Upside(The 5 Minute Wrapup)

Sep 4, 2019

Lakshmi Vilas Bank is in a vicious cycle. The stock is already down 57% in 2019. Despite this, the retail investors increased their holding.

Insider Buying Alert: Promoters Increase Stake in 8 High-Quality Smallcaps(Profit Hunter)

Sep 3, 2019

Insiders have increased their stakes in eight Hidden Treasure recommendations. Should you follow them?

Buy these 7 Stocks if You Believe in India(The 5 Minute Wrapup)

Sep 12, 2019

News headlines predict gloom and doom for India these days. You should ignore them.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

ELDER PHARMA SHARE PRICE


Sep 12, 2016 (Close)

TRACK ELDER PHARMA

  • Track your investment in ELDER PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

ELDER PHARMA 8-QTR ANALYSIS

COMPARE ELDER PHARMA WITH

MARKET STATS